Shanghai Kaibao Pharmaceutical
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and… Read more
Shanghai Kaibao Pharmaceutical (300039) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.042x
Based on the latest financial reports, Shanghai Kaibao Pharmaceutical (300039) has a cash flow conversion efficiency ratio of 0.042x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥190.98 Million) by net assets (CN¥4.55 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Kaibao Pharmaceutical - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Shanghai Kaibao Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanghai Kaibao Pharmaceutical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Kaibao Pharmaceutical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gas Malaysia Bhd
KLSE:5209
|
0.049x |
|
Xiamen Jihong Package Technology Ltd
SHE:002803
|
-0.014x |
|
Quanta Storage
TWO:6188
|
-0.024x |
|
Ethan Allen Interiors Inc
NYSE:ETD
|
0.027x |
|
Acrobiosystems Co.Ltd.
SHE:301080
|
N/A |
|
Family Zone Cyber Safety Limited
PINK:FMZNF
|
-0.050x |
|
Qinhuangdao Port Co Ltd
SHG:601326
|
0.048x |
|
SP Setia Bhd
KLSE:8664
|
0.020x |
Annual Cash Flow Conversion Efficiency for Shanghai Kaibao Pharmaceutical (2006–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Kaibao Pharmaceutical from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.10 Billion | CN¥278.95 Million | 0.068x | -28.35% |
| 2023-12-31 | CN¥4.03 Billion | CN¥382.66 Million | 0.095x | -5.19% |
| 2022-12-31 | CN¥3.76 Billion | CN¥376.42 Million | 0.100x | +141.71% |
| 2021-12-31 | CN¥3.04 Billion | CN¥126.08 Million | 0.041x | -57.41% |
| 2020-12-31 | CN¥2.58 Billion | CN¥250.65 Million | 0.097x | -25.23% |
| 2019-12-31 | CN¥2.57 Billion | CN¥334.09 Million | 0.130x | +23.16% |
| 2018-12-31 | CN¥2.49 Billion | CN¥262.36 Million | 0.106x | +1.62% |
| 2017-12-31 | CN¥2.37 Billion | CN¥245.76 Million | 0.104x | -27.40% |
| 2016-12-31 | CN¥2.20 Billion | CN¥314.88 Million | 0.143x | -12.25% |
| 2015-12-31 | CN¥2.01 Billion | CN¥327.08 Million | 0.163x | +8.85% |
| 2014-12-31 | CN¥1.88 Billion | CN¥282.38 Million | 0.150x | -10.95% |
| 2013-12-31 | CN¥1.61 Billion | CN¥270.23 Million | 0.168x | -1.89% |
| 2012-12-31 | CN¥1.42 Billion | CN¥243.32 Million | 0.171x | +132.79% |
| 2011-12-31 | CN¥1.33 Billion | CN¥98.31 Million | 0.074x | +360.54% |
| 2010-12-31 | CN¥1.24 Billion | CN¥19.79 Million | 0.016x | -65.23% |
| 2009-12-31 | CN¥1.15 Billion | CN¥52.74 Million | 0.046x | -68.76% |
| 2008-12-31 | CN¥126.92 Million | CN¥18.70 Million | 0.147x | -51.29% |
| 2007-12-31 | CN¥76.96 Million | CN¥23.27 Million | 0.302x | -42.84% |
| 2006-12-31 | CN¥37.24 Million | CN¥19.70 Million | 0.529x | -- |